Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.03 CAD | 0.00% | +20.00% | 0.00% |
Business Summary
Number of employees: 2
Managers
Managers | Title | Age | Since |
---|---|---|---|
Michael Frank
CEO | Chief Executive Officer | - | 19-12-17 |
Carmelo Marrelli
DFI | Director of Finance/CFO | 53 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Michael Frank
CEO | Chief Executive Officer | - | 19-12-17 |
William Jackson
BRD | Director/Board Member | - | 13-12-31 |
Andrew Lindzon
BRD | Director/Board Member | 63 | 19-12-17 |
Director/Board Member | 50 | 19-12-17 | |
Joshua Herman
BRD | Director/Board Member | - | 19-12-17 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 418,564,269 | 412,444,735 ( 98.54 %) | 0 | 98.54 % |
Company contact information
Revive Therapeutics Ltd.
The Canadian Venture Building 82 Richmond Street East
M5C 1P1, Toronto
+888-901-0036
http://www.revivethera.comSector
1st Jan change | Capi. | |
---|---|---|
0.00% | 9.18M | |
+9.15% | 105B | |
-1.08% | 104B | |
+5.79% | 22.94B | |
-11.55% | 22.34B | |
-7.01% | 19.25B | |
-37.08% | 17.08B | |
-9.91% | 16.96B | |
+7.55% | 14.16B | |
+40.04% | 12.63B |
- Stock Market
- Equities
- RVV Stock
- Company Revive Therapeutics Ltd.